Mittelmeerdiät übertrifft Low-FODMAP-Plan zur Linderung von IBS-Symptomen | Die Studie ergab außerdem, dass die Diät weitere Vorteile mit sich bringen könnte: Sie kann dazu beitragen, das Risiko von Herzerkrankungen, Krebs, Demenz und Diabetes zu verringern.

From the article: In this latest [study](https://www.acpjournals.org/doi/10.7326/ANNALS-25-01519), researchers found that after six weeks, a 50-point or greater reduction in IB-SSS score was achieved by 62% of those assigned the Mediterranean diet, compared with 42% of participants eating the low-FODMAP plan. There was also a greater reduction in mean IBS-SSS score on the Mediterranean diet and frequency of abdominal pain was significantly improved among these participants, compared with the FODMAP cohort.

However, earlier this year, University of Michigan researchers found that the low-FODMAP diet to be marginally more effective (81.8% versus 73% on the Mediterranean diet for four weeks). The team noted at the time that symptom relief came at a cost, with trial participants reporting some challenges with the low-FODMAP plan.

“Restrictive diets, such as low FODMAP, can be difficult for patients to adopt,” said Prashant Singh, Michigan Medicine gastroenterologist and lead author on the April 2025 paper. “In addition to the issue of being costly and time-consuming, there are concerns about nutrient deficiencies and disordered eating when trying a low FODMAP diet. The Mediterranean diet interested us as an alternative that is not an elimination diet and overcomes several of these limitations related to a low FODMAP diet.”

In a 2024 Australian trial of 59 adults with IBS, researchers found that over six weeks, there was greater adherence for those on the Mediterranean diet, as well as improved gastrointestinal and psychological symptoms over that period.

While it’s too early to say definitively that one plan is better than the other for overall relief, researchers note that the Mediterranean diet „represents a viable first-line dietary intervention for IBS,“ and warrants larger studies. What’s more, the diet could deliver other benefits beyond symptom relief, with existing evidence that it can help reduce the risk of heart disease, cancer, dementia and diabetes.